https://www.selleckchem.com/pr....oducts/CP-690550.htm
This study aimed to investigate whether an increased proton pump inhibitor (PPI) dose enhanced the efficacy of Helicobacter pylori (H.pylori) eradication and determine the appropriate cutoff intragastric pH value that could predict H.pylori eradication with bismuth-based quadruple therapy. A total of 207 H.pylori infected, treatment naive patients were enrolled in this prospective, open-label, randomized controlled trial. Patients were randomly allocated into Eso40-group (esomeprazole 40mg bid) and Eso20-group (esomeprazole 20mg bid),
Me gusta
Comentario
Compartir
